Yifan Pharmaceutical announced that its wholly-owned subsidiaries Hefei Yifan Biopharmaceutical Co., Ltd. and Liaoning Yifan Pharmaceutical Co., Ltd. participated in the bidding organized by the Joint Procurement Office for the tenth batch of national pharmaceutical centralized procurement, and some products are intended to be selected for this centralized procurement. The intended selected products include Lacosamide injection, Dexamethasone injection, Nimodipine injection, and Methacholine injection.
亿帆医药：全资子公司部分产品拟中选第十批全国药品集中采购
Yifan Pharmaceutical: The wholly-owned subsidiary's products are intended to be selected for the tenth batch of national pharmaceutical centralized procurement.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha